Around WCM

Graduating Weill Cornell Medicine-Qatar medical students joined their New York City counterparts during Match Day on March 21 to learn where they matched for their residencies.

Students from Cornell’s Master of Public Health program and faculty from Weill Cornell Medicine’s Department of Pediatrics recently joined forces at the United Nations Foundation’s Shot@Life Advocate to Vaccinate Summit to champion global vaccine access.

An program developed by NewYork-Presbyterian and Weill Cornell Medicine that combines physician telehealth with home health care administered by paramedics helps reduce hospital readmissions for patients with heart failure and other chronic conditions, according to new research.

A generous grant from The Hearst Foundations will fund a new Program for the Study and Support of Caregivers at Weill Cornell Medicine, developing new strategies to help people cope with the challenges of caring for friends or family members at home.

Dr. Jim Hu was awarded a grant from the Prevent Cancer Foundation to support and innovate initiatives aimed at reducing misinformation, improving patient decision making, and addressing disparities in prostate cancer diagnosis and treatment.

Dr. Jacqueline Burré and a team of researchers were recently awarded an R01 grant from the National Institute of Neurological Disorders and Stroke expected to be $3.9 million over five years. 

The Weill Cornell Medicine Department of Neurological Surgery has made a major advancement in its Tanzania Neurosurgery Program by launching the region’s first dedicated endoscopy training program. The course provided a hands-on training experience for local surgeons, furthering the program’s commitment to enhancing neurosurgical care in East Africa.  

The Weill Cornell Medicine Program for Substance Use and Stigma of Addiction has proudly distributed naloxone rescue kits (Narcan) to the New York City community for 10 years.

The relationship between a patient and their provider can significantly influence the quality of care outcomes, particularly when considering provider race concordance, according to a new study led by a Weill Cornell Medical College student.

A new study reveals how the SARS-CoV-2 virus evolved from initially prioritizing increased transmissibility to enhanced immune evasion after the Omicron variant emerged according to Weill Cornell Medicine-Qatar (WCM-Q) researchers.

On January 14th, Weill Cornell Medicine’s Core Laboratories Center held its inaugural WCM Cores Day in the Griffis Faculty Club, showcasing the institution’s research core facilities to more than 240 attendees from across WCM, including faculty, staff, postdocs, and students.

Accelerating BioVenture Innovation program Dec. 5 graduated another cohort with its signature pitch finale in Uris Auditorium and a networking reception.

Weill Cornell Medicine and Champions Oncology signed a licensing agreement allowing Champions Oncology to distribute and commercialize Weill Cornell Medicine’s extensive bank of hematological PDX models

Weill Cornell Medicine recently hosted the New York Pathological Society's Fall Mini-Symposium. 

Though using large language models (LLM) that drive artificial intelligence (AI) to draft patient notes shows promise in saving physicians time, they will still need to review and edit these summaries for accuracy, finds a new study by researchers at Weill Cornell Medicine. 

USF Health and Weill Cornell Medicine researchers have published the first version of their clinically validated voice dataset to an online artificial intelligence platform to serve as an invaluable resource for investigators across the globe.  

Researchers at Weill Cornell Medicine have developed breast cancer cell-of-origin signatures that can better predict both overall and progression-free survival of patients with breast cancer compared to previously developed genomic signatures.

A ribbon-cutting ceremony celebrates the opening of a new pediatric sub-specialty practice at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

Scientists at Weill Cornell Medicine in Qatar (WCM-Q) have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules measured in blood, urine and saliva samples from 391 volunteers.

A comprehensive genomic and molecular profiling approach can provide a more definitive, personalized treatment strategy for patients with cancer of unknown origin.